53.95
price down icon0.73%   -0.3891
 
loading
前日終値:
$54.34
開ける:
$53.87
24時間の取引高:
1.07M
Relative Volume:
0.45
時価総額:
$133.03B
収益:
$48.03B
当期純損益:
$6.06B
株価収益率:
21.60
EPS:
2.4983
ネットキャッシュフロー:
$9.91B
1週間 パフォーマンス:
-1.02%
1か月 パフォーマンス:
-0.97%
6か月 パフォーマンス:
-4.10%
1年 パフォーマンス:
+13.09%
1日の値動き範囲:
Value
$53.78
$54.44
1週間の範囲:
Value
$53.78
$55.99
52週間の値動き範囲:
Value
$45.22
$60.12

Sanofi Adr Stock (SNY) Company Profile

Name
名前
Sanofi Adr
Name
セクター
Healthcare (1165)
Name
電話
-
Name
住所
-
Name
職員
82,878
Name
Twitter
@sanofi
Name
次回の収益日
2024-10-25
Name
最新のSEC提出書
Name
SNY's Discussions on Twitter

SNY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
SNY
Sanofi Adr
53.98 133.03B 48.03B 6.06B 9.91B 2.4983
Drug Manufacturers - General icon
LLY
Lilly Eli Co
811.82 719.11B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
ABBV
Abbvie Inc
204.15 359.93B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
JNJ
Johnson Johnson
154.80 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
68.36 301.99B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
110.37 216.49B 51.72B 11.94B 13.81B 5.88

Sanofi Adr Stock (SNY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-21 開始されました Goldman Neutral
2025-01-30 アップグレード Deutsche Bank Sell → Hold
2024-07-26 繰り返されました Argus Buy
2024-01-23 開始されました Morgan Stanley Equal-Weight
2024-01-16 再開されました UBS Buy
2023-12-05 ダウングレード JP Morgan Overweight → Neutral
2023-10-30 ダウングレード Stifel Buy → Hold
2023-09-06 アップグレード Berenberg Hold → Buy
2023-07-14 開始されました HSBC Securities Buy
2023-04-28 ダウングレード Deutsche Bank Hold → Sell
2023-03-27 アップグレード Barclays Equal Weight → Overweight
2022-12-13 再開されました Morgan Stanley Overweight
2022-08-12 アップグレード Deutsche Bank Sell → Hold
2022-08-09 ダウングレード UBS Buy → Neutral
2022-05-23 開始されました SVB Leerink Outperform
2021-09-27 アップグレード SVB Leerink Mkt Perform → Outperform
2021-01-15 開始されました Deutsche Bank Sell
2020-09-29 開始されました Berenberg Hold
2020-03-17 アップグレード Barclays Underweight → Equal Weight
2020-03-11 アップグレード Goldman Neutral → Buy
2020-02-11 開始されました SVB Leerink Mkt Perform
2020-01-06 アップグレード JP Morgan Neutral → Overweight
2019-09-23 アップグレード Guggenheim Neutral → Buy
2019-09-20 アップグレード Morgan Stanley Equal-Weight → Overweight
2019-09-03 開始されました Bernstein Outperform
2019-08-14 アップグレード UBS Neutral → Buy
2018-12-11 アップグレード Jefferies Hold → Buy
2018-11-01 アップグレード Barclays Underweight → Equal Weight
2018-10-09 開始されました Guggenheim Neutral
2018-09-10 アップグレード BofA/Merrill Neutral → Buy
2018-08-10 アップグレード Citigroup Neutral → Buy
2018-03-23 アップグレード Liberum Hold → Buy
2018-01-23 ダウングレード Barclays Equal Weight → Underweight
2017-12-06 ダウングレード BofA/Merrill Buy → Neutral
2017-12-01 ダウングレード Morgan Stanley Overweight → Underweight
2017-11-15 アップグレード Barclays Underweight → Equal Weight
2017-08-30 アップグレード HSBC Securities Reduce → Hold
すべてを表示

Sanofi Adr (SNY) 最新ニュース

pulisher
Mar 31, 2025

FDA Approves Sanofi's Hemophilia Drug - Benzinga

Mar 31, 2025
pulisher
Mar 27, 2025

Led by Dupixent, Solid Immunology Position Helps Support Steady Long-Term Growth for Sanofi - Morningstar

Mar 27, 2025
pulisher
Mar 27, 2025

4 healthcare stocks attractive on valuation and ESG risk - Morningstar Australia

Mar 27, 2025
pulisher
Mar 18, 2025

SNY Quantitative Stock Analysis - Nasdaq

Mar 18, 2025
pulisher
Mar 17, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 17, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 12, 2025

Know Labs Inc (KNW) Stock: A Closer Look at the Market Potential - The News Heater

Mar 12, 2025
pulisher
Mar 04, 2025

European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView

Mar 04, 2025
pulisher
Feb 27, 2025

Piper Sandler Shows Market Leadership With Jump To 83 RS Rating - Inkl

Feb 27, 2025
pulisher
Feb 26, 2025

Sanofi ADR Shows Market Leadership With Jump To 82 RS Rating - Investor's Business Daily

Feb 26, 2025
pulisher
Feb 25, 2025

Gold Field ADR Sees Its Composite Rating Rise To 99 - Inkl

Feb 25, 2025
pulisher
Feb 24, 2025

ZEEKR Intelligent ADR Shows Rising Price Performance With Jump To 80 RS Rating - Inkl

Feb 24, 2025
pulisher
Feb 17, 2025

Validea Detailed Fundamental AnalysisSNY - Nasdaq

Feb 17, 2025
pulisher
Feb 14, 2025

Harrow Earns Relative Strength Rating Upgrade - Inkl

Feb 14, 2025
pulisher
Feb 13, 2025

Sanofi ADR Earns RS Rating Upgrade - Investor's Business Daily

Feb 13, 2025
pulisher
Feb 11, 2025

Newmont Earns RS Rating Upgrade - Inkl

Feb 11, 2025
pulisher
Feb 07, 2025

What was Skechers U S A, Inc (SKX)’s performance in the last session? - US Post News

Feb 07, 2025
pulisher
Feb 07, 2025

Sanofi ADR (SNY) requires closer examination - US Post News

Feb 07, 2025
pulisher
Feb 05, 2025

Sanofi ADR (SNY): A Technical Analysis - The News Heater

Feb 05, 2025
pulisher
Feb 05, 2025

GNPX’s Market Whiplash: -38.94% YTD Decline, -42.28% Plunge in 30 Days - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

Applied Materials Inc’s Banking’s 100-Day Moving Average at 182.60: Will the Stock Break Through? - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

ESPR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 05, 2025
pulisher
Feb 04, 2025

Regeneron Pharmaceuticals Beats On Libtayo's Back, Unveils Dividend - Investor's Business Daily

Feb 04, 2025
pulisher
Feb 03, 2025

Waltham biotech plans to raise $150M in IPO this week - The Business Journals

Feb 03, 2025
pulisher
Jan 30, 2025

Sanofi Reports Strong Q4 Sales Growth, Plans €5 Billion Buyback in 2025 - GuruFocus.com

Jan 30, 2025
pulisher
Jan 30, 2025

Sanofi ADR earnings beat by $0.53, revenue fell short of estimates - Investing.com South Africa

Jan 30, 2025
pulisher
Jan 30, 2025

Sanofi ADR (SNY) Recovers 15.33% From Low: Are We There Yet? - Stocks Register

Jan 30, 2025
pulisher
Jan 29, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Jan 29, 2025

Sanofi Adr (SNY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$111.16
price down icon 0.12%
drug_manufacturers_general PFE
$24.57
price up icon 0.13%
$304.94
price down icon 0.68%
drug_manufacturers_general MRK
$86.31
price down icon 0.91%
drug_manufacturers_general NVS
$110.38
price up icon 0.69%
大文字化:     |  ボリューム (24 時間):